Search Results - "Trés, Alejandro"

Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial by García-Carbonero, Rocio, Mayordomo, José I., Tornamira, María V., López-Brea, Marta, Rueda, Antonio, Guillem, Vicente, Arcediano, Alberto, Yubero, Alfonso, Ribera, Fernando, Gómez, Carlos, Trés, Alejandro, Pérez-Gracia, José L., Lumbreras, Carlos, Hornedo, Javier, Cortés-Funes, Hernan, Paz-Ares, Luis

“…Background: Granulocyte colony-stimulating factors (G-CSFs) have been shown to help prevent febrile neutropenia in certain subgroups of cancer patients…”
Get full text

Assessment of the evolution of cancer treatment therapies by Arruebo, Manuel, Vilaboa, Nuria, Sáez-Gutierrez, Berta, Lambea, Julio, Tres, Alejandro, Valladares, Mónica, González-Fernández, Africa

“…Cancer therapy has been characterized throughout history by ups and downs, not only due to the ineffectiveness of treatments and side effects, but also by hope…”
Get full text

Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review by García, Joaquín J., López-Pingarrón, Laura, Almeida-Souza, Priscilla, Tres, Alejandro, Escudero, Pilar, García-Gil, Francisco A., Tan, Dun-Xian, Reiter, Russel J., Ramírez, Jose M., Bernal-Pérez, Milagros

“…Free radicals generated within subcellular compartments damage macromolecules which lead to severe structural changes and functional alterations of cellular…”
Get full text

Phase III Multicenter Clinical Trial of the Sialyl‐TN (STn)‐Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer by Miles, David, Roché, Henri, Martin, Miguel, Perren, Timothy J., Cameron, David A., Glaspy, John, Dodwell, David, Parker, Joanne, Mayordomo, José, Tres, Alejandro, Murray, James Lee, Ibrahim, Nuhad K.

“…Purpose. This double‐blind, randomized, phase III clinical trial evaluated time to progression (TTP) and overall survival in women with metastatic breast…”
Get full text

Randomized, Phase III Trial of Sequential Epirubicin and Docetaxel Versus Epirubicin Alone in Postmenopausal Patients With Node-Positive Breast Cancer by COOMBES, R. Charles, BLISS, Judith M, WARDLEY, Andrew, KILBURN, Lucy S, COOPER, Derek, THOMAS, Marina W. K, REISE, Justine A, WILKINSON, Katie, HUPPERETS, Pierre, ESPIE, Marc, ERDKAMP, Frans, WALS, Jacob, TRES, Alejandro, MARTY, Michel, COLEMAN, Robert E, TUBIANA-MATHIEU, Nicole, DEN BOER, Marinus O

“…The Docetaxel Epirubicin Adjuvant (DEVA) trial evaluated the efficacy and toxicity of incorporating docetaxel after epirubicin to create a sequential…”
Get full text

Biweekly Docetaxel and Vinorelbine as First-Line Chemotherapy in Metastatic Breast Cancer by Mayordomo, Jose I., Millá, Alfredo, Morales, Serafín, Yubero, Alfonso, Lorenzo, Antonio, Baena, José M., Modolell, Alfonso, Sanz, Javier, Illarramendi, Jose, García, María J., Machengs, Ignacio, Burillo, Miguel A., Tres, Alejandro

“…This study was designed to evaluate the antitumor activity and tolerance of biweekly docetaxel plus vinorelbine as first-line chemotherapy in patients with…”
Get full text

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 by Amundadottir, Laufey T, Ghosh, Shyamali, Sigurdsson, Asgeir, Sun, Jielin, Ober, Carole, Mayordomo, Jose I, Jonsson, Eirikur, Barkardottir, Rosa B, Saemundsdottir, Jona, Agnarsson, Bjarni A, Suarez, Brian K, Witjes, J Alfred, Stacey, Simon N, Swinkels, Dorine W, Einarsson, Gudmundur V, Benediktsdottir, Kristrun R, Gulcher, Jeffrey R, Gudmundsson, Julius, Thorsteinsdottir, Unnur, Baker, Adam, Navarrete, Sebastian, Albers-Akkers, Marjo T, Kong, Augustine, Jakobsdottir, Margret, Tres, Alejandro, Walsh, Patrick C, Stefansson, Kari, Xu, Jianfeng, Aben, Katja K, Godino-Ivan Marcos, Javier, Blondal, Thorarinn, Kostic, Jelena, Isaacs, Sarah D, Mouy, Magali, Kiemeney, Lambertus A, Gudbjartsson, Daniel, Isaacs, William B, Ruiz-Echarri, Manuel, Helgason, Agnar, Frigge, Mike, Rafnar, Thorunn, Bergthorsson, Jon T, Kristjansson, Kristleifur, Wiley, Kathleen E, Backman, Valgerdur M, Cashy, John, Catalona, William J, Sulem, Patrick, Manolescu, Andrei, Partin, Alan W, Graif, Theresa

“…Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions, with African American men having among the highest worldwide incidence…”
Get full text

Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes by Borch-Johnsen, Knut, Ghosh, Shyamali, Tong, Peter C Y, Sigurdsson, Asgeir, Asin, Laura, So, Wing-Yee, Hofker, Marten H, Ober, Carole, Jonsson, Eirikur, Palmer, Colin N A, Saez, Berta, Kimber, Charlotte H, Frigge, Michael L, Barkardottir, Rosa B, Agnarsson, Bjarni A, Suarez, Brian K, Bagger, Yu, Wilensky, Robert L, Stacey, Simon N, Swinkels, Dorine W, Hansen, Torben, Einarsson, Gudmundur V, Benediktsdottir, Kristrun R, Gulcher, Jeffrey R, Gudmundsson, Julius, Wijmenga, Cisca, Sigurdsson, Gunnar, Morris, Andrew D, Thorsteinsdottir, Unnur, Tres, Alejandro, Olafsdottir, Adalheidur, Baker, Adam, Magnusdottir, Dana, Chen, Yuanxiu, Thorleifsson, Gudmar, Adeyemo, Adebowale, Fuertes, Fernando, Kong, Augustine, Jakobsdottir, Margret, Kiemeney, Lambertus A, Ng, Maggie C Y, Kristinsson, Kari T, Stefansson, Kari, Klaver, Siem, van Vierssen Trip, Onco, Chan, Juliana C N, Aben, Katja K, Benediktsson, Rafn, Birgisdottir, Birgitta, Blondal, Thorarinn, Jorgensen, Torben, Thorlacius, Steinunn, Stefansdottir, Gerdur, Gudbjartsson, Daniel, Zhou, Jie, Rotimi, Charles, Ruiz-Echarri, Manuel, Mayordomo, Jose I, Helgason, Agnar, Rader, Daniel J, Pedersen, Oluf, Gunnarsdottir, Steinunn, Reilly, Muredach P, van Boven, Erica, Rafnar, Thorunn, Bergthorsson, Jon T, Kristjansson, Kristleifur, Cashy, John, Catalona, William J, Sulem, Patrick, Steinthorsdottir, Valgerdur, Andersen, Gitte, Manolescu, Andrei, Christiansen, Claus, Graif, Theresa

“…We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer…”
Get full text

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer by Stacey, Simon N, Stefansson, Kari, Manolescu, Andrei, Sulem, Patrick, Rafnar, Thorunn, Gudmundsson, Julius, Gudjonsson, Sigurjon A, Masson, Gisli, Jakobsdottir, Margret, Thorlacius, Steinunn, Helgason, Agnar, Aben, Katja K, Strobbe, Luc J, Albers-Akkers, Marjo T, Swinkels, Dorine W, Henderson, Brian E, Kolonel, Laurence N, Le Marchand, Loic, Millastre, Esther, Andres, Raquel, Godino, Javier, Garcia-Prats, Maria Dolores, Polo, Eduardo, Tres, Alejandro, Mouy, Magali, Saemundsdottir, Jona, Backman, Valgerdur M, Gudmundsson, Larus, Kristjansson, Kristleifur, Bergthorsson, Jon T, Kostic, Jelena, Frigge, Michael L, Geller, Frank, Gudbjartsson, Daniel, Sigurdsson, Helgi, Jonsdottir, Thora, Hrafnkelsson, Jon, Johannsson, Jakob, Sveinsson, Thorarinn, Myrdal, Gardar, Grimsson, Hlynur Niels, Jonsson, Thorvaldur, von Holst, Susanna, Werelius, Barbro, Margolin, Sara, Lindblom, Annika, Mayordomo, Jose I, Haiman, Christopher A, Kiemeney, Lambertus A, Johannsson, Oskar Th, Gulcher, Jeffrey R, Thorsteinsdottir, Unnur, Kong, Augustine

“…Familial clustering studies indicate that breast cancer risk has a substantial genetic component. To identify new breast cancer risk variants, we genotyped…”
Get full text

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer by Stacey, Simon N, Stefansson, Kari, Manolescu, Andrei, Sulem, Patrick, Thorlacius, Steinunn, Gudjonsson, Sigurjon A, Jonsson, Gudbjörn F, Jakobsdottir, Margret, Bergthorsson, Jon T, Gudmundsson, Julius, Aben, Katja K, Strobbe, Luc J, Swinkels, Dorine W, van Engelenburg, K C Anton, Henderson, Brian E, Kolonel, Laurence N, Le Marchand, Loic, Millastre, Esther, Andres, Raquel, Saez, Berta, Lambea, Julio, Godino, Javier, Polo, Eduardo, Tres, Alejandro, Picelli, Simone, Rantala, Johanna, Margolin, Sara, Jonsson, Thorvaldur, Sigurdsson, Helgi, Jonsdottir, Thora, Hrafnkelsson, Jon, Johannsson, Jakob, Sveinsson, Thorarinn, Myrdal, Gardar, Grimsson, Hlynur Niels, Sveinsdottir, Steinunn G, Alexiusdottir, Kristin, Saemundsdottir, Jona, Sigurdsson, Asgeir, Kostic, Jelena, Gudmundsson, Larus, Kristjansson, Kristleifur, Masson, Gisli, Fackenthal, James D, Adebamowo, Clement, Ogundiran, Temidayo, Olopade, Olufunmilayo I, Haiman, Christopher A, Lindblom, Annika, Mayordomo, Jose I, Kiemeney, Lambertus A, Gulcher, Jeffrey R, Rafnar, Thorunn, Thorsteinsdottir, Unnur, Johannsson, Oskar T, Kong, Augustine

“…We carried out a genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016…”
Get full text

Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast by Vidal, Maria, Peg, Vicente, Galván, Patricia, Tres, Alejandro, Cortés, Javier, Ramón y Cajal, Santiago, Rubio, Isabel T., Prat, Aleix

“…Fibroepithelial tumors (FTs) of the breast are a heterogeneous group of lesions ranging from fibroadenomas (FAD) to phyllodes tumors (PT) (benign, borderline,…”
Get full text

Effects of an exercise training program on the quality of life of women with breast cancer on chemotherapy by Moros, Ma Teresa, Ruidiaz, Mercedes, Caballero, Ana, Serrano, Enrique, Martínez, Víctor, Tres, Alejandro

“…Exercise may reduce anxiety and depression associated to the diagnosis and treatment of cancer. To assess the effects of a physical training program during…”
Get full text

Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma by Visús, Carmen, Andres, Raquel, Mayordomo, Jose I, Martinez-Lorenzo, María J, Murillo, Laura, Sáez-Gutiérrez, Berta, Diestre, Clara, Marcos, Ivan, Astier, Pilar, Godino, Javier, Carapeto-Marquez de Prado, Francisco J, Larrad, Luis, Tres, Alejandro

“…A need for factors predictive of prognosis is present in patients who are diagnosed with malignant melanoma. The detection of circulating melanoma cells by…”
Get full text

Ejercicio físico en mujeres con cáncer de mama by MOROS, Mª TERESA, RUIDIAZ, MERCEDES, CABALLERO, ANA, SERRANO, ENRIQUE, MARTÍNEZ, VÍCTOR, TRES, ALEJANDRO

Get full text

Gemcitabine/Capecitabine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes by Andres, Beth, Mayordomo, Jose Ignacio, Lara, Ricardo, Lastra, Rodrigo, Ortega, Eugenia, Polo, Eduardo, Lambea, Julio, Isla, Dolores, Saenz-Cusi, Alberto, Escudero, Pilar, Tres, Alejandro

“…Gemcitabine and capecitabine are 2 anticancer drugs with a mechanism of action involving metabolism of pyrimidine nucleotides. Both are among the few agents…”
Get full text

Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma by Andrés, Raquel, Mayordomo, Jose I, Visus, Carmen, Isla, Dolores, Godino, Javier, Escudero, Pilar, Saenz, Alberto, Ortega, Eugenia, Lastra, Rodrigo, Lambea, Julio, Aguirre, Elena, Elosegui, Luis, Marcos, Ivan, Ruiz-Echarri, Manuel, Millastre, Esther, Sáez-Gutierrez, Berta, Asin, Laura, Vidal, Maria J, Ferrer, Ana, Giner, Armando, Larrad, Luis, Carapeto, Francisco J, Tres, Alejandro

“…The utility of many molecules as tumor markers in melanoma has been investigated with different results. The aims of this study was to compare the value of…”
Get full text

Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma by García, Margarita, del Muro, Xavier García, Tres, Alejandro, Crespo, Carmen, Valladares, Manuel, López, Juan José, Rifà, Julio, Pérez, Xavier, Filipovich, Elena, Germà-Lluch, Josep Ramón

“…Temozolomide is a novel oral alkylating agent, active against metastatic melanoma. Combinations of chemotherapy and biological response modifiers have been…”
Get full text

Common variants on chromosome 5pl2 confer susceptibility to estrogen receptor-positive breast cancer by STACEY, Simon N, MANOLESCU, Andrei, STROBBE, Luc J, SWINKELS, Dorine W, VAN ENGELENBURG, K. C. Anton, HENDERSON, Brian E, KOLONEL, Laurence N, LE MARCHAND, Loic, MILLASTRE, Esther, ANDRES, Raquel, SAEZ, Berta, LAMBEA, Julio, SULEM, Patrick, GODINO, Javier, POLO, Eduardo, TRES, Alejandro, PICELLI, Simone, RANTALA, Johanna, MARGOLIN, Sara, JONSSON, Thorvaldur, SIGURDSSON, Helgi, JONSDOTTIR, Thora, HRAFNHKELSSON, Jon, THORLACIUS, Steinunn, JOHANNSSON, Jakob, SVEINSSON, Thorarinn, MYRDAL, Gardar, NIELS GRIMSSON, Hlynur, SVEINSDOTTIR, Steinunn G, ALEXIUSDOTTIR, Kristin, SAEMUNDSDOTTIR, Jona, SIGURDSSON, Asgeir, KOSTIC, Jelena, GUDMUNDSSON, Larus, GUDJONSSON, Sigurjon A, KRISTJANSSON, Kristleifur, MASSON, Gisli, FACKENTHAL, James D, ADEBAMOWO, Clement, OGUNDIRAN, Temidayo, OLOPADE, Olufunmilayo I, HAIMAN, Christopher A, LINDBLOM, Annika, MAYORDOMO, Jose I, KIEMENEY, Lambertus A, JONSSON, Gudbjorn F, GULCHER, Jeffrey R, RAFHAR, Thorunn, THORSTEINSDOTTIR, Unnur, JOHANNSSON, Oskar T, KONG, Augustine, STEFANSSON, Kari, JAKOBSDOTTIR, Margret, BERGTHORSSON, Jon T, GUDMUNDSSON, Julius, ABEN, Katja K

Get full text

Detection of specific T cells for 264-272 and 149-157 peptides of p53 protein in peripheral blood of patients with breast cancer by Alvarez-Busto, Iñaki, Albers, Andreas, Visus, María Carmen, Mayordomo, José Ignacio, Sanz, Javier, Burillo, Miguel Angel, Güemes, Antonio, García-Prats, María Dolores, Moros, Manuel, De Leo, Albert, Tres, Alejandro

“…p53 protein is overexpressed in nearly half of all human tumours. An HLA-A2.1-restricted immunological response mediated by anti-p53 CD8+ T cells directed…”
Get more information

Case 4. Hypertrophic osteoarthropathy associated with pulmonary metastasis of uterine leiomyosarcoma by Andrés, Raquel, Saenz, Alberto, Mayordomo, José I, Zaballos, Pedro, Isla, Dolores, Escudero, Pilar, Alvarez, Ignacio, Polo, Eduardo, Lara, Ricardo, Tres, Alejandro

Get full text